MREO — Mereo BioPharma Group plc
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1719714 ·
United Kingdom
Last close
$0.33
Market Cap
$53.26M
52W High
$0.42
52W Low
$0.22
ADV30
2,519,953
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -8,671,000 | -6,719,000 | 40,614,000 | 36,223,000 | 6,560,000 |
| Dec 2025 | 0 | 0 | -7,917,000 | -7,351,000 | 45,917,000 | 40,992,000 | 5,001,000 |
| Sep 2025 | 0 | 0 | -9,569,000 | -7,024,000 | 53,602,000 | 48,698,000 | 7,004,000 |
| Jun 2025 | 500,000 | 368,000 | -9,754,000 | -14,616,000 | 62,631,000 | 56,125,000 | 8,454,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-30,971,000
Investing CF
$-20,000
Financing CF
$327,000
CapEx
$-320,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.35
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-501,018,000
Inventory
—
Receivables
$1,983,000
ST Investments
—
EBIT TTM
$-41,623,000
Pretax Income TTM
$-41,878,000
Interest Exp TTM
$255,000
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$500,000
EBITDA
$-35,577,500
Free Cash Flow
—
Enterprise Value
$185,882,336
Total Cash
$36,223,000
Total Debt
$0
Shares Out
159,618,609
Trailing EPS
$-0.20
Book Value
$0.21
ROE
-75.9%
ROA
-41.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 500,000 | -38,257,000 | -41,878,000 | 45,917,000 | 5,001,000 | — | -30,971,000 |
| Dec 2024 | 0 | -45,715,000 | -43,253,000 | 76,390,000 | 15,421,000 | — | -32,834,000 |
| Dec 2023 | 10,000,000 | -27,136,000 | -29,466,000 | 66,499,000 | 15,962,000 | — | -21,132,000 |
| Dec 2022 | 0 | -52,698,000 | -42,220,000 | 77,413,000 | 26,011,000 | — | -48,821,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.04
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| KZR | Kezar Life Sciences, Inc. | $53.86M | $7.29 | — |
| ACTU | ACTUATE THERAPEUTICS, INC. | $52.64M | $2.20 | — |
| SCYX | SCYNEXIS INC | $54.10M | $0.68 | — |
| GOSS | Gossamer Bio, Inc. | $51.63M | $0.22 | — |
| IBO | IMPACT BIOMEDICAL INC. | $55.20M | $0.51 | — |
News headlines (Yahoo Finance, 1h cache)
European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading
2026-05-26 15:09 · Yahoo
European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading
2026-05-22 15:06 · Yahoo
European Equities Traded in the US as American Depositary Receipts Open Week Tracking Higher in Monday Trading
2026-05-18 15:11 · Yahoo
European Equities Traded in the US as American Depositary Receipts Flat in Wednesday Trading
2026-05-13 15:12 · Yahoo
European Equities Traded in the US as American Depositary Receipts Decline Sharply in Tuesday Trading
2026-05-12 15:14 · Yahoo
Mereo BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates
2026-05-12 11:30 · Yahoo
European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading
2026-05-11 15:05 · Yahoo
European Equities Traded in the US as American Depositary Receipts Climb Sharply Higher in Wednesday Trading
2026-05-06 15:10 · Yahoo
European Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading
2026-05-05 15:08 · Yahoo
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
2026-04-30 15:06 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.